ALK Gene Rearrangement Testing in Non-Small Cell Lung Carcinoma by ThinPrep-FISH

被引：0
|
作者：
Mince, E. C. [1 ]
Portier, B. P. [1 ]
Wang, Z. [1 ]
Brainard, J. [1 ]
Farver, C. [1 ]
Feng, Y. [1 ]
Ma, P. C. [1 ]
Arrossi, V. [1 ]
Pennel, N. [1 ]
Tubbs, R. R. [1 ]
机构：
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
来源：
LABORATORY INVESTIGATION | 2013年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1914
引用
收藏
页码：460A / 460A
页数：1
相关论文
共 50 条
  • [31] Percentage of ALK Rearrangement as a Response Predictor in Non-Small Cell Lung Cancer Treatment
    Oliveira, M.
    Natal, R.
    Costa, J.
    Gomes, R.
    Amaral, A.
    Ferreira, L.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1076 - S1077
  • [32] Development of a novel ALK rearrangement screening test for non-small cell lung cancers
    Chen, Yi-Lin
    Chen, Wan-Li
    Cheng, Yi-Chia
    Lin, Ming-Ching
    Yang, Shu-Ching
    Tsai, Hung-Wen
    Lin, Chien-Chung
    Su, Wu-Chou
    Chow, Nan-Haw
    Ho, Chung-Liang
    PLOS ONE, 2021, 16 (09):
  • [33] An activating ALK gene mutation in ALK IHC-positive/FISH-negative non-small cell lung cancer
    Togashi, Yosuke
    Mizuuchi, Hiroshi
    Sakai, Kazuko
    Banno, Eri
    Hayashi, Hidetoshi
    de Velasco, Marco
    Fujita, Yoshihiko
    Tomida, Shuta
    Mitsudomi, Tetsuya
    Nishio, Kazuto
    ANNALS OF ONCOLOGY, 2015, 26 : 73 - 73
  • [34] Replacement of ALK inhibitors as an effective strategy for reducing drug toxicity in non-small cell lung cancer patients with ALK gene rearrangement
    Gil, Michal
    Chmielewska, Izabela
    Krawczyk, Pawel
    Nizinski, Przemyslaw
    Strzemski, Maciej
    Milanowski, Janusz
    ONCOLOGY IN CLINICAL PRACTICE, 2023, 18 (03): : 190 - 196
  • [35] CUX1-ALK, a Novel ALK Rearrangement That Responds to Crizotinib in Non-Small Cell Lung Cancer
    Zhang, Meiling
    Wang, Qian
    Ding, Yan
    Wang, Guoqun
    Chu, Yunqian
    He, Xiang
    Wu, Xue
    Shao, Yang W.
    Lu, Kaihua
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (11) : 1792 - 1797
  • [36] Next-generation sequencing discordant ALK-rearrangement in non-small cell lung carcinoma with ovarian metastases
    Tan, Charles Jeffrey Lay
    Li, Rubi K.
    ANNALS OF ONCOLOGY, 2023, 34 : S1460 - S1460
  • [37] Immunohistochemistry May Not Be a Reliable Screening Tool for Identification of ALK Rearrangement (ALKR) in Non-Small Cell Lung Carcinoma (NSCLC)
    Conklin, C. M. J.
    Craddock, K. J.
    Have, C.
    Tsao, M.
    Couture, C.
    Ionescu, D. N.
    LABORATORY INVESTIGATION, 2012, 92 : 475A - 475A
  • [38] Immunohistochemistry May Not Be a Reliable Screening Tool for Identification of ALK Rearrangement (ALKR) in Non-Small Cell Lung Carcinoma (NSCLC)
    Conklin, C. M. J.
    Craddock, K. J.
    Have, C.
    Tsao, M.
    Couture, C.
    Ionescu, D. N.
    MODERN PATHOLOGY, 2012, 25 : 475A - 475A
  • [39] A case report of metastatic bilateral ovarian cancer due to non-small cell lung cancer with ALK gene rearrangement
    Liu, Zhitong
    Liu, Bo
    Li, Changzhong
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2019, 40 (01) : 151 - 153
  • [40] Crizotinib for ALK rearrangement in non small cell lung cancer
    Merrick, S. A.
    Hunter, S.
    Dalby, M.
    Neat, M.
    McMunagle, E.
    Montes, A.
    Lal, R.
    Ghosh, S.
    LUNG CANCER, 2017, 103 : S29 - S30
12345